Vital Technologies develops and markets fast-acting, pharma-class recovery beverage products aimed at healthy individuals who experience transient physiological and cognitive stress. The company has launched CUUR®, a product designed to preemptively target symptoms caused by alcohol consumption. CUUR® is manufactured in a pharma-class GMP facility registered with the U.S. Food and Drug Administration. Vital plans to use recent funding for R&D, production and marketing of CUUR® in the U.S. The company was founded in 2015 and is led by CEO Amir Barzilay. The team also includes Irit Livny (VP Marketing), Doron Polity (VP Operations) and Dr. Michael Fox (Head of Formulation Development).

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2019